Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer - Concepedia

Concepedia

Publication | Open Access

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer

DOI Full Paper Access

1.1K

Citations

35

References

2003

Year

Gerrit Draisma, Rob Boer, Suzie J. Otto, Ingrid W van der Cruijsen, Ronald Damhuis, F.H. Schröder, Harry J. de Koning

JNCI Journal of the National Cancer Institute

Abstract

These model-based lead-time estimates support a prostate cancer screening interval of more than 1 year.

References

	Year	Citations

Page 1